HK1093721A1 - Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it - Google Patents

Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it

Info

Publication number
HK1093721A1
HK1093721A1 HK06114155.6A HK06114155A HK1093721A1 HK 1093721 A1 HK1093721 A1 HK 1093721A1 HK 06114155 A HK06114155 A HK 06114155A HK 1093721 A1 HK1093721 A1 HK 1093721A1
Authority
HK
Hong Kong
Prior art keywords
preparing
pharmaceutical compositions
compositions containing
ibopamine
ibopamine maleate
Prior art date
Application number
HK06114155.6A
Other languages
English (en)
Inventor
Mario Pinza
Caterina Maugeri
Nicola Cazzolla
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1093721A1 publication Critical patent/HK1093721A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK06114155.6A 2004-01-30 2006-12-27 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it HK1093721A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000146A ITMI20040146A1 (it) 2004-01-30 2004-01-30 Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono
PCT/EP2005/000445 WO2005075409A1 (en) 2004-01-30 2005-01-13 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
HK1093721A1 true HK1093721A1 (en) 2007-03-09

Family

ID=34835573

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06114155.6A HK1093721A1 (en) 2004-01-30 2006-12-27 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it

Country Status (20)

Country Link
US (1) US7667069B2 (pt)
EP (1) EP1708988B1 (pt)
JP (1) JP4646921B2 (pt)
KR (1) KR101109566B1 (pt)
CN (1) CN100564351C (pt)
AT (1) ATE502004T1 (pt)
AU (1) AU2005211453B2 (pt)
BR (1) BRPI0507153A (pt)
CA (1) CA2551411C (pt)
DE (1) DE602005026909D1 (pt)
DK (1) DK1708988T3 (pt)
EA (1) EA009212B1 (pt)
ES (1) ES2361520T3 (pt)
HK (1) HK1093721A1 (pt)
IL (1) IL176431A (pt)
IT (1) ITMI20040146A1 (pt)
PL (1) PL1708988T3 (pt)
PT (1) PT1708988E (pt)
SI (1) SI1708988T1 (pt)
WO (1) WO2005075409A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091156A1 (es) * 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
WO2022099195A1 (en) * 2020-11-09 2022-05-12 The Board Of Trustees Of The Leland Stanford Junior University Ophthalmic formulation containing a dopaminergic prodrug that may be combined with one or more agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2400038A (en) * 1944-09-07 1946-05-07 Burroughs Wellcome Co Esters of secondary phenolic amines
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
IT1178800B (it) * 1984-12-27 1987-09-16 Simes Composizioni farmaceutiche e loro uso come midriatici
IT1231488B (it) * 1988-11-09 1991-12-07 Zambon Spa Soluzione acquosa farmaceutica tamponata a ph 4,5 per uso oftalmico contenente ibopamina e idrossipropilmetilcellulosa
IT1247508B (it) * 1991-04-19 1994-12-17 Zambon Spa Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Also Published As

Publication number Publication date
IL176431A0 (en) 2006-10-05
JP4646921B2 (ja) 2011-03-09
DE602005026909D1 (de) 2011-04-28
CA2551411C (en) 2012-04-24
ATE502004T1 (de) 2011-04-15
EP1708988B1 (en) 2011-03-16
BRPI0507153A (pt) 2007-07-31
KR101109566B1 (ko) 2012-01-31
SI1708988T1 (sl) 2011-06-30
US20080242724A1 (en) 2008-10-02
CN100564351C (zh) 2009-12-02
PL1708988T3 (pl) 2011-08-31
AU2005211453B2 (en) 2011-06-30
CA2551411A1 (en) 2005-08-18
KR20060127940A (ko) 2006-12-13
US7667069B2 (en) 2010-02-23
PT1708988E (pt) 2011-05-31
IL176431A (en) 2010-11-30
ES2361520T3 (es) 2011-06-17
EA200601117A1 (ru) 2006-10-27
CN1910139A (zh) 2007-02-07
JP2007519657A (ja) 2007-07-19
ITMI20040146A1 (it) 2004-04-30
WO2005075409A1 (en) 2005-08-18
AU2005211453A1 (en) 2005-08-18
DK1708988T3 (da) 2011-06-27
EA009212B1 (ru) 2007-12-28
EP1708988A1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
AU2003303598A8 (en) Compositions, methods, and systems for inferring bovine breed
ME01400B (en) Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
AP2280A (en) Compositions and methods for increasing telomeraseactivity.
IL175300A0 (en) Indirubin-type compounds, compositions, and methods for their use
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
WO2004113297A3 (en) Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
IL186062A0 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
AU2003286474A8 (en) Compositions, solutions, and methods used for transplantation
HK1093721A1 (en) Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
IL183438A0 (en) Substituted indoles, compositions containing them, method for the production thereof and their use
SI1587810T1 (sl) NOVI SUBSTITUIRANI DERIVATI 1,4 BENZODIOKSINO 2,3-e IZOINDOLA, POSTOPEK ZA NJIHOVO PRIPRAVO IN FARMACEVTSKI SESTAVKI, KI JIH VSEBUJEJO
EP1515960A4 (en) 2-THIOXOTHIAZOL DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
HK1093962A1 (en) L-(-)-moprolol-l-(+)-tartrate
EP1506180A4 (en) THIAZOLIDINE-4-ONE DERIVATIVE, PROCESS FOR PREPARING THEM, AND PHARMACEUTICAL COMPOSITION BASED ON THE DERIVATIVE
AU2002245649A1 (en) Methods, compositions and kits for preserving antigenicity
AU2003232684A8 (en) Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
PL112907U1 (en) Set of small containers, in particular that for displaying flower compositions
AU2003292349A1 (en) 4-methyl-2-oxo-2h-1-benzopyran-7yl 5-thio-beta-d-xylopyranoside derivative, method for preparing same and pharmaceutical composition containing same
MY135292A (en) Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200113